No­vo Nordisk turns to Evotec to build ear­ly-stage pipeline for di­a­betes, obe­si­ty drugs

The Eu­ro­pean dis­cov­ery out­fit at Evotec has signed up an­oth­er ma­jor league play­er in bio­phar­ma, and they’re prep­ping an ear­ly-stage pipeline right where their part­ner …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.